key: cord-0939084-fo9gfk53 authors: Seale, Lucia A; Torres, Daniel J; Berry, Marla J; Pitts, Matthew W title: A role for selenium-dependent GPX1 in SARS-CoV-2 virulence date: 2020-06-27 journal: Am J Clin Nutr DOI: 10.1093/ajcn/nqaa177 sha: 4ab472c91e20ae334c75249d297272976e3160d6 doc_id: 939084 cord_uid: fo9gfk53 nan The relation between selenium, GPX1, ebselen, and SARS-CoV-2 M pro (Nsp5). Selenium (Se) availability regulates expression of GPX1, which, in turn, mitigates oxidative stress. If left unchecked, oxidative stress promotes viral mutagenesis. The selenium-containing compound ebselen mimics GPX activity and is a potent inhibitor of M pro (Nsp5). GPX1 also interacts with M pro in a yet-to-be-characterized fashion. M pro is essential for viral replication. GPX1, glutathione peroxidase 1; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2. adequate, case-fatality rates are substantially lower (∼6%) relative to Europe. Among the proteins most impacted by selenium status is glutathione peroxidase 1 (GPX1), a cytosolic selenoenzyme with known antiviral properties. Viral infection increases reactive oxygen species (ROS) production in host cells, which, if not counterbalanced by antioxidant defense mechanisms, leads to oxidative stress. Excess oxidative stress, in turn, augments mutation of the viral genome, which can lead to the emergence of more virulent strains. GPX1 comprises a key defense against ROS, catalyzing the detoxification of hydrogen peroxide to water. In mice lacking the Gpx1 gene (Gpx1 −/− ), inoculation of a benign strain of coxsackievirus B3 (CVB3) led to viral genome mutations, increased virulence, and myocarditis, none of which were observed in wild-type mice (6) . Moreover, the Gpx1 −/− model recapitulated the effect of a seleniumdeficient diet in wild-type mice, promoting mutagenesis of the benign CVB3 strain into a virulent one (6) . In addition, both selenium-deficient wild-type mice (6) and Gpx1 −/− mice (7) exhibit heightened inflammatory responses and more severe lung pathology in response to inoculation with influenza A, further indicating that GPX1 participates in molecular mechanisms protecting against viral infections of the respiratory tract. It is currently unknown whether SARS-CoV-2 is also modulated by GPX1 activity, but recent findings are highly suggestive. Immediately prior to the aforementioned publication of Zhang et al., 2 separate articles provided evidence of a relation between GPX1 and M pro , the main protease of SARS-CoV-2. M pro promotes formation of the viral replication complex and hence is a target of great interest for therapeutic intervention. The 3-dimensional crystal structure of M Pro was recently described (8) , leading to the identification of potential antiviral compounds through structure-assisted drug design and virtual screening. Beginning from a pool of >10,000 compounds, the organoselenium compound, ebselen, emerged as the strongest inhibitor of M pro . Ebselen is widely considered a GPX1 mimetic, as it reduces ROS via a mechanism similar to that of GPX1, whereby the selenol group is oxidized and subsequently reduced by glutathione (9) . Correspondingly, the potential involvement of GPX1 in COVID-19 was also highlighted in a separate study investigating the SARS-CoV-2 human protein interactome. Herein, Gordon et al. (10) expressed 26 of the 29 putative SARS-CoV-2 viral proteins in HEK293 cells and screened for potential interaction partners through affinity purification followed by MS quantification. For the SARS-CoV-2 protease M pro , screening was conducted using wild-type and a catalytically inactive mutant version of M pro (Nsp5 C145A) to circumvent promiscuous covalent binding to the catalytic cysteine sulfhydryl group. Three interacting proteins of high confidence were identified, histone deacetylase 2 (HDAC2), tRNA (guanine-26-(N-2))-dimethyltransferase (TRMT1), and GPX1. Taken together, the parallel findings of M pro inhibition by the GPX1-mimetic ebselen and a physical interaction between M pro and GPX1 further allude to an important protective role for GPX1 against COVID-19. Here, we suggest that the interaction between the GPX1 detoxifying system and the main protease (M pro ) of SARS-CoV-2 represents a novel molecular target for COVID-19 (Figure 1 ). If proven, this interaction points to a key role for host selenium status in combating SARS-CoV-2 virulence, with selenium deficiency worsening clinical outcomes. This notion is further supported by the report of Zhang et al., demonstrating a positive association between selenium status and COVID-19 cure rates in China. Given that patient GPX1 activity may greatly impact prognosis and disease severity, probing for selenium concentrations among both symptomatic and asymptomatic SARS-CoV-2-infected individuals warrants prioritization. This may provide novel insights into mechanisms leading to the severity of COVID-19 and gauge the demographic most likely to benefit from selenium supplementation and/or ebselen treatment in the fight against COVID-19. Selenium, selenoproteins and viral infection Association between regional selenium status and reported outcome of COVID-19 cases in China Selenium and human health An interactive web-based dashboard to track COVID-19 in real time A review of dietary selenium intake and selenium status in Europe and the Middle East Selenium deficiency and viral infection Glutathione peroxidase-1 reduces influenza A virus-induced lung inflammation Structure of M(pro) from COVID-19 virus and discovery of its inhibitors Ebselen, a selenoorganic compound as glutathione peroxidase mimic A SARS-CoV-2 protein interaction map reveals targets for drug repurposing We thank Richard Yanagihara, Jeffrey Friedman, Margaret McFall-Ngai, and Edward Ruby for critical feedback on this commentary.All authors conceptualized, drafted, and revised the text. The authors are supported by NIH grants U54 MD007601, P20 GM103466, and R01DK47320. The authors report no conflicts of interest.